BioVentrix Inc.
Minimally invasive and non-surgical treatments for HF
This article was originally published in Start Up
Executive Summary
The most prevalent kind of heart failure is caused by heart attack damage to the left ventricle, and the standard treatment is an open-heart procedure called surgical ventricular restoration. BioVentrix Inc. aims to replace SVR with a less invasive version of the procedure, using its Revivent Myocardial Anchoring System, designed to pull the damaged segments of the left ventricle together to reduce the burden on the non-damaged myocardium and improve its performance.